Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

Does The Work Of The National Institute For Health And Clinical Excellence (NICE) Have Any Relevance For The United States?

The growing emphasis on evidence-based decision-making in health care, especially regarding health technologies, has generated notable debate and discussion in the U.S. around establishing a more formalized process or system for conducting comparative effectiveness research. In the eyes of many observers, this is quite similar to the health technology assessment programs existing in a number of European countries. The National Institute for Health and Clinical Excellence (NICE) in the U.K. is one the most discussed and debated systems currently in operation, since it represents one of the most sophisticated national attempts to systematically review the value, or relative costs and benefits, of various treatments. The National Pharmaceutical Council commissioned a study of NICE in order to understand its methods of working and to explore its relevance to the United States.

Newsletter Volume

E.V.I.dently October 2014

Message From NPCMind the Gap: Improving Quality Measurement in Accountable Care SystemsOur society is obsessed with quality, from the cars that we...
Blog Post

CER Tweets of the Week: Fendrick Elected to IOM, GAO Calls to Fill PCORI Methodology Committee Seat & More (October 20-24)

This week, comparative effectiveness research (CER) stakeholders tweeted about new appointments and open positions at top health care organizations....
Blog Post

CER Tweets of the Week: The State of Accountable Care, JAMA on PCORI’s Perspective, Real-World Impact of CER (October 13-17)

Health care stakeholders tweeted about accountable care, patient-centered outcomes research (PCOR) and the real-world impact of comparative...
Blog Post

CER Tweets of the Week: Health Affairs on the High Value of Specialty Medications, Pediatric CER Guidelines, Patient Heterogeneity (October 6-10)

This week, comparative effectiveness research (CER) stakeholders tweeted articles about specialty medications, CER guidelines and individual...
Press Release

Fellowship in Health Care Policy Available Through a Partnership of the National Pharmaceutical Council and Milken Institute School of Public Health at The George Washington University

WASHINGTON, DC (September 17, 2014)–The National Pharmaceutical Council (NPC), in conjunction with Milken Institute School of Public Health (Milken...
Press Release

NPC Study Outlines When & How Health Decision-Makers Should Consider Individual Patient Differences

Washington, DC (July 29, 2014)—New research led by the National Pharmaceutical Council (NPC) can assist health care stakeholders to understand when...
Press Release

NPC Annual Stakeholder Survey: Comparative Effectiveness Research Is Important, But Impact on Health Care Decision-Making Is Still on the Horizon

(Washington, DC, May 19, 2014)—A new survey of health care stakeholders reveals continued optimism for the use of comparative effectiveness research...
Press Release

CER Collaborative Improving Health Outcomes Through New Comparative Evidence Tools

(Washington, DC, March 24, 2014)—Three peer-reviewed articles published in Value in Health offer important guidance to aid formulary decision-makers...
Commentary and Testimony Page

The State of CER and the Environment for Health Care Decision Making

This month, NPC released its third annual survey on stakeholders’ views on comparative effectiveness research (CER), “The State of Comparative...
Commentary and Testimony Page

Keeping Our Eye on the CER Ball

Until the cherry blossoms begin to bloom later next month, most of the water cooler conversations in Washington will focus on the federal budget....
Commentary and Testimony Page

Leveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?

A growing chorus of voices is publicly sharing data on the effectiveness of treatment options, but one viewpoint has long been shut out of key areas...
Commentary and Testimony Page

Living Up to Its Name? The Role of Patient-Centered Research

Anyone who has ever received bad news from his or her health care provider or held a loved one’s hand when a diagnosis was delivered can understand...
YouTube Videos

Health Technology Assessments and Specialty Medications

David Grainger, senior director, global public policy, Eli Lilly and Company, says that there are often challenges in conducting health technology...
YouTube Videos

Differences in Global Health Technology Assessment

David Grainger, senior director, global public policy, Eli Lilly and Company, describes how health technology assessment (HTA) informs policy and...
YouTube Videos

Incorporating Patient Views Into Health Technology Assessments

David Grainger, senior director, global public policy, Eli Lilly and Company, explains that many health technology assessments are incorporating...
YouTube Videos

Real-World Impact of Comparative Effectiveness Research Findings on Clinical Practice

National Pharmaceutical Council Chief Science Officer Robert W. Dubois, MD, PhD, discusses a peer-reviewed study suggesting that changes are needed...
Blog Post

CER Tweets of the Week: Fendrick Elected to IOM, GAO Calls to Fill PCORI Methodology Committee Seat & More (October 20-24)

This week, comparative effectiveness research (CER) stakeholders tweeted about new appointments and open positions at top health care organizations....
Blog Post

CER Tweets of the Week: The State of Accountable Care, JAMA on PCORI’s Perspective, Real-World Impact of CER (October 13-17)

Health care stakeholders tweeted about accountable care, patient-centered outcomes research (PCOR) and the real-world impact of comparative...
Blog Post

CER Tweets of the Week: Health Affairs on the High Value of Specialty Medications, Pediatric CER Guidelines, Patient Heterogeneity (October 6-10)

This week, comparative effectiveness research (CER) stakeholders tweeted articles about specialty medications, CER guidelines and individual...
Blog Post

CER Tweets of the Week: Reports on Health Care Quality, Fellowships, and PCORI Turns 4

A report on health care quality from the U.S. Department of Health and Human Services, postdoctoral fellowships and the Patient-Centered Outcomes...

Research

  •  
  • 1 of 41
  • >

Commentary & Testimony